Related Experiment Video

Updated: Feb 25, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Effects of lipid-based nutrient supplements v. micronutrient powders on nutritional and developmental outcomes among

Susana L Matias1, Alejandro Vargas-Vásquez2, Ricardo Bado Pérez3

  • 11Department of Nutrition,University of California,Davis,One Shields Avenue,Davis,CA 95616,USA.

Public Health Nutrition
|August 10, 2017
PubMed

Insights

Lipid-based nutrient supplements (LNS) improved hemoglobin and cognitive skills in children aged 6-12 months compared to micronutrient powder (MNP). LNS did not significantly impact linear growth or motor and language development.

Area of Science:

  • Pediatric Nutrition
  • Public Health Interventions
  • Child Development

Background:

  • Micronutrient deficiencies are a major global health concern in young children.
  • Lipid-based nutrient supplements (LNS) and micronutrient powders (MNP) are common strategies to address these deficiencies.
  • Comparative effectiveness of LNS versus MNP on child health outcomes requires further investigation.

Purpose of the Study:

  • To compare the effects of LNS versus MNP on hemoglobin (Hb) levels, linear growth, and developmental outcomes in children.
  • To evaluate the impact of daily LNS and MNP supplementation over six months on child health indicators.

Main Methods:

  • A two-arm parallel-group randomized controlled trial was conducted in rural Peru.
  • 422 children aged 6 months were randomized to receive either LNS or MNP for six months.
  • Outcomes including Hb, anthropometry, and developmental milestones (motor, language, problem-solving) were assessed at 12 months of age.

Main Results:

  • Children receiving LNS showed significantly higher mean Hb concentration and lower odds of anemia compared to the MNP group.
  • LNS supplementation was associated with improved problem-solving skills in children.
  • No significant differences were observed in anthropometric indicators (stunting, underweight) or gross motor and receptive language development between the groups.

Conclusions:

  • LNS supplementation from 6 to 12 months of age effectively increases hemoglobin, reduces anemia, and enhances cognitive development in children.
  • LNS did not demonstrate significant benefits over MNP for anthropometric measures or motor and language development.
  • These findings support the use of LNS for improving specific health and cognitive outcomes in young children.
Abstract

Keywords:
AnaemiaChild developmentLipid-based nutrient supplementMicronutrient powderPeruProblem solvingStunting

More Related Videos

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

813
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

2.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
375
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
388
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
263